hrp0082p2-d3-496 | Endocrine Oncology | ESPE2014

Endocrine Dysfunction Following Treatment of Medulloblastoma: a Single Centre Experience

Uday Suma , Raju Midhu , Alvi Sabah

Introduction: Medulloblastoma is the commonest paediatric brain tumour and accounts for 20–30% of all brain tumours in the first decade of life. Improvements in treatment strategies have enhanced long-term survival resulting in an increased risk of late sequelae.Aim: Review the prevalence of endocrine dysfunction in survivors of medulloblastoma at a single centre.Methods: Case note review of patients treated for medulloblastom...